Latest S-1 registration statements

Sow Good Inc. files an amendment to its Form S-1 registration statement, signaling its intent to proceed with a public offering and potential listing on the Nasdaq Capital Market.

CleanCore Solutions finalizes a $500,000 revolving credit agreement with Clayton Adams and adjusts its lease terms as it prepares for its initial public offering.

BestGofer Inc. is registering 2,080,000 common shares held by selling shareholders at a fixed price of $0.04 per share, with the intention of seeking quotation on the OTC Markets after the registration statement is effective.

BIOLASE, Inc. has filed a registration statement for the resale of up to 4,443,760 shares of its common stock, which are issuable upon the exercise of outstanding warrants held by a selling stockholder.

Fidelity is seeking SEC approval for its Fidelity Ethereum Fund, an exchange-traded product designed to track the performance of ether, the native token of the Ethereum blockchain.

Spyre Therapeutics is filing an amendment to its registration statement for the resale of up to 12 million shares of its common stock by selling stockholders.

FibroBiologics files an amendment to its S-1 registration statement to register the resale of approximately 1.5 million shares of common stock by GEM Global Yield LLC SCS and GEM Yield Bahamas Limited.

Actelis Networks has filed an amendment to its Form S-1 registration statement, covering the resale of up to 3,697,154 shares of common stock by selling stockholders.

Ensysce Biosciences is registering for the potential issuance and resale of up to 7,455,627 shares of common stock underlying warrants held by selling securityholders.

PACS Group, a leading post-acute healthcare company, has filed an amendment to its S-1 registration statement for an initial public offering of its common stock, with plans to list on the New York Stock Exchange under the symbol PACS.

Shorepower Technologies aims to register 25,817,272 shares of common stock for resale, including shares underlying warrants, to fund acquisitions and working capital.

Cyclacel Pharmaceuticals is launching a best efforts public offering of common stock, common stock warrants, and pre-funded warrants to raise capital for working capital and general corporate purposes.

Armlogi Holding Corp. files an amendment to its Form S-1 registration statement solely to include an updated consent from its independent auditor, ZH CPA, LLC.

Cortigent, a neurostimulation technology company, is seeking to raise approximately $15 million through an initial public offering to fund the development of its Orion visual prosthesis and stroke recovery system.

Churchill Capital Corp IX files for a $250 million IPO, offering units consisting of one Class A ordinary share and one-quarter of a warrant, aiming for a business combination.

CO2 Energy Transition Corp. files an amendment to its S-1 registration statement for a proposed initial public offering focused on the carbon capture, utilization, and storage industry.

High Roller Technologies aims to raise capital for expansion through an initial public offering, as detailed in its latest S-1/A filing.

Waystar Holding Corp. files an amendment to its S-1 registration statement for its upcoming initial public offering.

Aethlon Medical, Inc. files for a best-efforts offering of common stock and warrants, aiming to raise up to $8 million for general corporate purposes.

ABVC BioPharma files an amendment to its Form S-1 registration statement to include information from its 2023 Annual Report on Form 10-K, pertaining to the resale of up to 11,714,683 shares of common stock by selling stockholders.

Centuri Holdings, Inc. files an S-1 form detailing a Registration Rights Agreement with Southwest Gas Holdings, outlining terms for future stock registrations.

Ibotta, Inc. has filed an S-1 registration statement for an initial public offering, seeking to expand its AI-driven platform that connects CPG brands with consumers through digital promotions.

Flag Ship Acquisition Corporation details its rights agreement in connection with its upcoming IPO, outlining terms for public and private rights.

Invech Holdings, Inc. has filed an amendment to its S-1 registration statement for the resale of up to 3,277,416 shares of common stock by selling stockholders.

Dianthus Therapeutics files an amendment to its S-1 registration statement to register the resale of common stock by selling stockholders.

Boundless Bio is seeking to raise capital through an IPO to further develop its ecDNA-directed cancer therapies and diagnostic tools.

Aptevo Therapeutics is launching a public offering to sell shares of common stock, pre-funded warrants, and common warrants to raise capital for working capital and general corporate purposes.

Black Hawk Acquisition Corporation files an amendment to its S-1 registration statement to register an additional 1,035,000 units for potential sale to the public.

Prairie Operating Co. files an amendment to its Form S-1 registration statement, including expert consents and updated financial information related to its proposed offering and recent acquisitions.

Biofrontera Inc. has filed an amendment to its registration statement for the resale of up to 9,310,678 shares of common stock by selling stockholders.